- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
EI
VIE
Week ended 07 Aug 2026
Weekly Investor Report
EssilorLuxottica Société anonyme · Healthcare · Medical Instruments & Supplies
Latest close
172.2 EUR
3.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -12.2% below the Trend Line and sits at 8.5% of its 52-week range. The latest completed week returned 3.4%, after a 0.5% four-week move. The latest news-sentiment score is 50/100.
Setup score
33
out of 100
Latest Close
172.2 EUR
7 Aug 2026
1W Return
3.4%
latest completed week
4W Return
0.5%
short-term follow-through
12W Return
-1.3%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 39.80% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.4%
Latest completed week; four-week move 0.5%.
Indicator stack
17/57
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Buy
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.80%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -12.2% below the Trend Line and sits at 8.5% of its 52-week range. The latest completed week returned 3.4%, after a 0.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1012-week average 0.10
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.5% over four weeks, -1.3% over 12 weeks, and -30.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.47Latest activity-pressure read.
Pressure change-16.8%Four-week change in activity pressure.
Leadership-40.81Latest relative-leadership reading.
RS change3.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalFresh
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-45.9%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2617 weeks finished lower.
Best week+6.9%Week of 17 Apr.
Worst week-13.7%Week of 24 Apr.
Latest week+3.4%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains6
Flat weeks0
Modest losses12
Sharp losses5
Recent vol2.7%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank56 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Medical Instruments & Supplies
4-week rank8 / 18
Group average3.2%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD83.3%positive activity pressure
RS11.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape29/100
Trend, activity pressure, participation, and risk combine to a 29/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 39.80%Next-week expectancy is negative with a 39.80% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalFreshActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
EssilorLuxottica Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 172.2 EUR | 3.4% | 196.1 EUR | 213.9 EUR | 0.47 | -40.81 | 2.2K | Off |
| 31 Jul 2026 | 166.6 EUR | 2.2% | 199.4 EUR | 213.9 EUR | 0.44 | -41.72 | 4.8K | Off |
| 24 Jul 2026 | 162.9 EUR | -2.3% | 202.6 EUR | 213.9 EUR | 0.40 | -43.73 | 1.3K | Off |
| 17 Jul 2026 | 166.8 EUR | -2.7% | 205.9 EUR | 213.9 EUR | 0.57 | -42.27 | 1.0K | Off |
| 10 Jul 2026 | 171.4 EUR | -0.3% | 209.4 EUR | 213.9 EUR | 0.56 | -42.40 | 2.8K | Off |
| 3 Jul 2026 | 172.1 EUR | 1.8% | 212.9 EUR | 213.8 EUR | 0.52 | -43.55 | 360 | Off |
| 26 Jun 2026 | 168.9 EUR | -2.6% | 217.0 EUR | 213.7 EUR | 0.31 | -43.78 | 662 | Off |
| 19 Jun 2026 | 173.4 EUR | -5.0% | 221.5 EUR | 213.6 EUR | 0.07 | -43.94 | 213 | Off |
| 12 Jun 2026 | 182.6 EUR | 5.3% | 225.7 EUR | 213.5 EUR | -0.16 | -39.14 | 523 | Off |
| 5 Jun 2026 | 173.4 EUR | -1.3% | 230.0 EUR | 213.3 EUR | -0.56 | -41.14 | 0 | Off |
| 29 May 2026 | 175.6 EUR | 1.1% | 234.2 EUR | 213.2 EUR | -0.67 | -41.61 | 204 | Off |
| 22 May 2026 | 173.8 EUR | -0.5% | 238.8 EUR | 213.1 EUR | -0.84 | -41.21 | 176 | Off |
| 15 May 2026 | 174.6 EUR | 0.8% | 243.1 EUR | 213.0 EUR | -0.92 | -40.31 | 100 | Off |
| 8 May 2026 | 173.1 EUR | -1.5% | 247.5 EUR | 213.0 EUR | -0.90 | -41.66 | 149 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.